Company profile: Alliqua
1.1 - Company Overview
Company description
- Provider of biomedical products and therapies, including custom electron-beam cross-linked hydrogels for medical and cosmetic applications and the UltraMIST ultrasound wound-healing therapy; develops, manufactures, and markets proprietary products leveraging a technology portfolio.
Products and services
- Custom Hydrogel Manufacturing: Alliqua BioMedical fabricates custom-engineered, electron-beam cross-linked hydrogels that incorporate various active ingredients for medical and cosmetic applications
- Proprietary Biomedical Product Development and Marketing: Alliqua BioMedical develops, fabricates, and markets proprietary biomedical products utilizing an integrated, platform-based technology portfolio
- UltraMIST Ultrasound Healing Therapy: Alliqua BioMedical developed a medical-grade therapy technology for wound healing, utilizing ultrasound-based therapeutic methods and approaches
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alliqua
BlueWillow Biologics
HQ: United States
Website
- Description: Provider of intranasal vaccine and adjuvant technologies, including an oil-in-water emulsion Intranasal Adjuvant Technology, NE01 adjuvanted intranasal vaccines, the BW-1010 anthrax vaccine candidate, and a therapeutic peanut allergy vaccine, built on the NanoVax platform to elicit mucosal, cellular, and systemic immunity; also focused on topical antiseptic and anti-infective products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BlueWillow Biologics company profile →
Milestone Scientific
HQ: United States
Website
- Description: Provider of computer-controlled injection technologies for medical and dental care, including the CompuFlo Epidural Instrument with visual/audio feedback to locate the epidural space; the STA Single Tooth Anesthesia system for precise dental delivery; DPS Dynamic Pressure Sensing and automated flow/pressure control for consistent injections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Milestone Scientific company profile →
H&T Presspart
HQ: United Kingdom
Website
- Description: Provider of drug delivery devices and manufacturing services for asthma and COPD, offering metered-dose inhalation devices and components (actuators, dose counters), dry powder inhalers including PowdAir Plus, comprehensive drug delivery device development from design to manufacturing, high-precision injection moulding, automated multi-component assembly, and deep drawing of metal components such as MDI cans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H&T Presspart company profile →
Qnovia
HQ: United States
Website
- Description: Provider of medtech and pharmaceutical drug-delivery solutions, including RespiRx, an inhalable prescription nicotine replacement therapy for smoking cessation; an inhaled drug delivery platform that optimizes and tracks dosing to improve efficacy and compliance; and a portable, orientation-agnostic vibrating mesh nebulizer with a digital metered dose interface, Bluetooth-enabled app, and a zero-maintenance disposable cartridge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qnovia company profile →
Clene
HQ: United States
Website
- Description: Provider of nanomedicine therapeutics for neurodegenerative diseases (ALS, MS, Parkinson's Disease), infectious diseases, and oncology applications: CNM-Au8 oral gold nanocrystals; CNM-ZnAg zinc-silver ionic solution with antiviral/antimicrobial properties; CNM-AgZn17 topical silver/zinc gel for infections and wound healing; CNM-PtAu7 gold-platinum nanotherapeutic with efficacy across tumor cell lines in initial research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clene company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alliqua
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alliqua
2.2 - Growth funds investing in similar companies to Alliqua
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alliqua
4.2 - Public trading comparable groups for Alliqua
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →